insights_auto
Why is BBOT down 2.78%?
Dive Deeperchevron_right
BBOT:NASDAQ
BridgeBio Oncology Therapeutics Inc
$3.50
arrow_downward
-2.78%(-0.100) 1D
$3.50
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 6, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BBOT...
Open
$3.60
High
$3.72
Low
$3.48
Mkt. cap
303.21M
Avg. vol.
647.50K
Volume
17.00
52-wk high
$14.87
52-wk low
$3.48
EPS
-$3.04
Shares outstanding
80.17M
No. of employees
88
Open
$3.60
High
$3.72
Low
$3.48
Mkt. cap
303.21M
Avg. vol.
647.50K
Volume
17.00
52-wk high
$14.87
52-wk low
$3.48
EPS
-$3.04
Shares outstanding
80.17M
No. of employees
88
News stories
From web sources and news partners
Simply Wall Street
·
13 minutes ago
Neurocrine Biosciences (NBIX) After New VYKAT XR Data Why The Undervalued Narrative Persists
Yahoo Finance
·
1 hour ago
S&P 500, Nasdaq hit records — but 'the breadth of the rally has narrowed': Chart of the Day
The Motley Fool
·
20 minutes ago
Is the S&P 500 Historically Expensive or Cheap? The Answer Depends on How You Look at It.
About BridgeBio Oncology Therapeutics Inc
CEO-
Employees88
Founded2016
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitebbotx.com